Rhythm Pharmaceuticals Inc (RYTM)
38.46
-0.71
(-1.81%)
USD |
NASDAQ |
May 17, 11:46
Rhythm Pharmaceuticals Cash from Financing (Quarterly): 4.243M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.243M |
| December 31, 2023 | 2.423M |
| September 30, 2023 | 73.04M |
| June 30, 2023 | -0.965M |
| March 31, 2023 | -0.133M |
| December 31, 2022 | 17.36M |
| September 30, 2022 | 158.56M |
| June 30, 2022 | 37.50M |
| March 31, 2022 | 0.399M |
| December 31, 2021 | 0.10M |
| September 30, 2021 | 0.413M |
| June 30, 2021 | 0.383M |
| March 31, 2021 | 165.58M |
| December 31, 2020 | 0.42M |
| September 30, 2020 | 0.699M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.183M |
| March 31, 2020 | 0.707M |
| December 31, 2019 | 161.96M |
| September 30, 2019 | 0.697M |
| June 30, 2019 | 0.498M |
| March 31, 2019 | 0.316M |
| December 31, 2018 | 0.153M |
| September 30, 2018 | 1.173M |
| June 30, 2018 | 163.36M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 125.66M |
| September 30, 2017 | 21.16M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 20.38M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.965M
Minimum
Jun 2023
165.58M
Maximum
Mar 2021
31.20M
Average
0.698M
Median
Cash from Financing (Quarterly) Benchmarks
| Pfizer Inc | -4.931B |
| Amicus Therapeutics Inc | -13.31M |
| Insmed Inc | 3.022M |
| Altimmune Inc | -0.261M |
| Regeneron Pharmaceuticals Inc | 47.10M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.74M |
| Cash from Investing (Quarterly) | 30.05M |
| Free Cash Flow | -140.47M |
| Free Cash Flow Per Share (Quarterly) | -0.6774 |
| Free Cash Flow to Equity (Quarterly) | -40.74M |
| Free Cash Flow to Firm (Quarterly) | -39.03M |
| Free Cash Flow Yield | -6.24% |